NovoCure Limited (NVCR) At $21.70 Forms Top; Last Week Philip Morris International Inc. (PM) Coverage

Among 19 analysts covering Philip Morris International (NYSE:PM), 12 have Buy rating, 0 Sell and 7 Hold. Therefore 63% are positive. Philip Morris International had 49 analyst reports since August 24, 2015 according to SRatingsIntel. Cowen & Co maintained the shares of PM in report on Thursday, July 20 with “Buy” rating. The stock of Philip Morris International Inc. (NYSE:PM) has “Buy” rating given on Friday, August 18 by Piper Jaffray. Stifel Nicolaus maintained the shares of PM in report on Wednesday, January 10 with “Buy” rating. The rating was upgraded by Societe Generale on Thursday, April 21 to “Hold”. The firm has “Neutral” rating given on Monday, November 30 by Nomura. The stock of Philip Morris International Inc. (NYSE:PM) has “Buy” rating given on Monday, August 24 by Vetr. The rating was maintained by Jefferies on Friday, October 20 with “Hold”. The stock of Philip Morris International Inc. (NYSE:PM) earned “Buy” rating by Goldman Sachs on Monday, October 3. The firm has “Buy” rating given on Tuesday, October 10 by Wells Fargo. The firm has “Hold” rating given on Tuesday, September 26 by Jefferies. See Philip Morris International Inc. (NYSE:PM) latest ratings:

11/01/2018 Broker: Piper Jaffray Rating: Buy New Target: $137.0 Maintain
10/01/2018 Broker: Stifel Nicolaus Rating: Buy New Target: $125.0 Maintain
15/11/2017 Broker: Wells Fargo Rating: Buy New Target: $135.0 Maintain
20/10/2017 Broker: Cowen & Co Rating: Buy New Target: $133.0 Maintain
19/10/2017 Broker: Piper Jaffray Rating: Buy New Target: $130.0 Maintain
20/10/2017 Broker: Jefferies Rating: Hold New Target: $114.0 Maintain
20/10/2017 Broker: Bank of America Rating: Neutral Old Target: $124 New Target: $121 Maintain
20/10/2017 Broker: Societe Generale Old Rating: Hold New Rating: Buy Upgrade
20/10/2017 Broker: Citigroup Rating: Neutral Old Target: $125 New Target: $117 Maintain
13/10/2017 Broker: Piper Jaffray Rating: Buy New Target: $135.0 Maintain

NovoCure Limited (NVCR) formed multiple top with $23.22 target or 7.00% above today’s $21.70 share price. NovoCure Limited (NVCR) has $1.94B valuation. The stock decreased 2.03% or $0.45 during the last trading session, reaching $21.7. About 753,535 shares traded. NovoCure Limited (NASDAQ:NVCR) has declined 0.43% since January 13, 2017 and is downtrending. It has underperformed by 17.13% the S&P500.

Analysts await NovoCure Limited (NASDAQ:NVCR) to report earnings on February, 22. They expect $-0.14 earnings per share, up 46.15% or $0.12 from last year’s $-0.26 per share. After $-0.13 actual earnings per share reported by NovoCure Limited for the previous quarter, Wall Street now forecasts 7.69% negative EPS growth.

Among 5 analysts covering NovoCure (NASDAQ:NVCR), 3 have Buy rating, 1 Sell and 1 Hold. Therefore 60% are positive. NovoCure had 6 analyst reports since October 27, 2015 according to SRatingsIntel. Barclays Capital initiated NovoCure Limited (NASDAQ:NVCR) rating on Tuesday, January 19. Barclays Capital has “Underweight” rating and $16 target. The rating was initiated by Wedbush on Tuesday, October 27 with “Outperform”. As per Wednesday, December 2, the company rating was initiated by Deutsche Bank. JP Morgan initiated the stock with “Overweight” rating in Tuesday, October 27 report. JMP Securities initiated NovoCure Limited (NASDAQ:NVCR) on Tuesday, October 27 with “Market Outperform” rating. Wedbush maintained the stock with “Outperform” rating in Friday, July 29 report.

The stock decreased 0.34% or $0.36 during the last trading session, reaching $104.5. About 5.51M shares traded or 24.08% up from the average. Philip Morris International Inc. (NYSE:PM) has risen 16.65% since January 13, 2017 and is uptrending. It has underperformed by 0.05% the S&P500.

Philip Morris International Inc., through its subsidiaries, makes and sells cigarettes, other tobacco products, and other nicotine-containing products. The company has market cap of $162.31 billion. The Company’s portfolio of brands comprises Marlboro, Merit, Parliament, Virginia S., L&M, Philip Morris, Bond Street, Chesterfield, Lark, Muratti, Next, and Red & White. It has a 23.07 P/E ratio. The firm also owns various cigarette brands, such as Dji Sam Soe, Sampoerna, and U Mild in Indonesia; Champion, Fortune, and Jackpot in the Philippines; Apollo-Soyuz and Optima in Russia; Morven Gold in Pakistan; Boston in Colombia; Belmont, Canadian Classics, and Number 7 in Canada; f6 in Germany; Delicados in Mexico; Assos in Greece; and Petra in the Czech Republic and Slovakia.

Investors sentiment increased to 0.97 in Q3 2017. Its up 0.09, from 0.88 in 2017Q2. It improved, as 55 investors sold Philip Morris International Inc. shares while 524 reduced holdings. 112 funds opened positions while 452 raised stakes. 1.10 billion shares or 0.12% more from 1.10 billion shares in 2017Q2 were reported. Walter & Keenan Fincl Consulting Mi Adv holds 0.64% or 12,450 shares in its portfolio. Wagner Bowman Mgmt Corporation reported 9,520 shares. Loudon Investment Limited Liability Company owns 2,432 shares for 0.21% of their portfolio. Highstreet Asset Management holds 0.06% or 5,911 shares in its portfolio. New England Private Wealth Advsr Limited Liability invested in 3,059 shares. Arizona State Retirement Systems has invested 0.55% in Philip Morris International Inc. (NYSE:PM). Brookstone Capital Management stated it has 57,108 shares or 0.57% of all its holdings. Rockefeller Finance Services accumulated 664 shares. Contravisory Inv Management has invested 0% of its portfolio in Philip Morris International Inc. (NYSE:PM). Wilbanks Smith And Thomas Asset Management Limited Liability Corporation owns 14,629 shares for 0.14% of their portfolio. Fiera Corporation owns 3,288 shares for 0% of their portfolio. S&T Savings Bank Pa invested in 0.04% or 1,949 shares. Monetary Management Incorporated stated it has 12,575 shares or 0.59% of all its holdings. The New Jersey-based Advsr Cap Management Lc has invested 1.39% in Philip Morris International Inc. (NYSE:PM). Paw Cap Corporation invested in 6,000 shares or 0.7% of the stock.